Company search
Overview
Performance
Portfolio
ESG
Dividends
Charges
Gearing
Research
Announcements
Management
Documents
Invest
Data as at: 03/10/2024
In
Objective
To seek capital appreciation through investment in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis.
AIC sector
Management group
Company website
Launch date
23/06/1997
March
Next AGM date
05/10/2024
Domicile
United Kingdom
Fund manager
Josh Golomb, Geoffrey C. Hsu
Dividend frequency
Data Not Available
Wind-up provisions
An opportunity to vote on the continuation of the Company is given to shareholders every five years. The next such continuation vote will be held at the AGM to be held in 2025.
| Market Cap (m) | Total assets (m) | Price (last close) | NAV | Discount / premium (%) | Gearing (%) | Dividend yield (%) | Dividend dates | Ongoing charge (%) |
|---|---|---|---|---|---|---|---|---|
| 328.59 | 370.79 | 1,028.00 | 1,095.80 | -6.19 | 5 | 0.00 | N/A | 1.2 (31/03/2024) |
Scroll
Dividends
Dividends declared in last 12 months
There have been no dividends in the last 12 months.
Performance (%)
| Return type | 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|---|
| Biotech Growth Trust | Share price total return | 36.3 | -12.4 | 49.0 | 82.3 |
| Biotechnology & Healthcare AIC sector | Share price total return | 12.7 | -9.2 | 13.6 | 108.5 |
Scroll
Share structure
Number of shares
31,963,979
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 53,904 | 1,450,982 | 17,740,134 | 109,635,847 |
| Average | N/A | 64,383 | 69,805 | 86,840 |
Scroll
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 0.55 | 15.03 | 163.93 | 1,164.64 |
| Average | N/A | 0.67 | 0.65 | 0.92 |
Scroll
Trading details
Top holdings
Data as at : 30/06/2024
| Investment | % of total assets |
|---|---|
| Amgen Inc | 8.1 |
| Biogen Inc | 6.1 |
| Regeneron Pharmaceuticals Inc | 4.6 |
| Sarepta Therapeutics Inc | 4.6 |
| Ionis Pharmaceuticals Inc | 3.5 |
| QuantumPharm Inc | 3.2 |
| argenx SE ADR | 3.0 |
| Alnylam Pharmaceuticals Inc | 2.7 |
| Janux Therapeutics Inc Ordinary Shares | 2.5 |
| Other Assets And Liabilities | -2.9 |
Data provided by Morningstar.
Company documents provided by FE fundinfo.
